logo

For the Inventor, By the Inventor

Jerusalem, Israel

Oramed Ltd.

Calculating rank
USPTO Granted Patents = 14



Trademarks = 1

Forward Citations = 127

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Miriam Kidron (9 out of 16 patents)

silverMedal Ramesh N Acharya (5 out of 7 patents)

bronzeMedal Avraham Hershko (2 out of 2 patents)

4.  Ehud Arbit (1 out of 18 patents)


14 patents:

1. 11660327 - Methods and compositions for oral administration of proteins (2023-05-30),
2. 11395848 - Methods and compositions for treating diabetes (2022-07-26),
3. 10967051 - Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof (2021-04-06),
4. 10933022 - Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same (2021-03-02),
5. 10881714 - Methods and compositions for oral administration of proteins (2021-01-05),
6. 10398762 - Methods and compositions for treating diabetes (2019-09-03),
7. 10350162 - Methods and compositions for oral administration of exenatide (2019-07-16),
8. 10342764 - Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same (2019-07-09),
9. 10058593 - Methods and compositions for oral administration of proteins (2018-08-28),
10. 5741805 - Controlled release pilocarpine delivery system (1998-04-21),
11. 5731338 - Controlled release pilocarpine delivery system (1998-03-24),
12. 5661171 - Controlled release pilocarpine delivery system (1997-08-26),
13. 5110605 - Calcium polycarbophil-alginate controlled release composition and method (1992-05-05),
14. 5102666 - Calcium polycarbophil controlled release composition and method (1992-04-07),
Company Overview
Oramed Ltd. is a biotechnology company based in Jerusalem, specializing in the development of innovative oral drug delivery systems. The company focuses on transforming injectable therapies into oral medications, particularly for diabetes and other metabolic diseases. By leveraging proprietary technology, Oramed aims to enhance patient compliance and improve treatment outcomes. Its research emphasizes the advancement of oral formulations that can effectively deliver therapeutic agents, positioning the company at the forefront of pharmaceutical innovation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#18 in Jerusalem

#463 in Israel

#42,312 in the World

Jerusalem, IL
Jerusalem, Israel

Oramed Ltd.

Forward Citations = 127

4 inventors:

goldMedal Miriam Kidron (9 out of 16 patents)

silverMedal Ramesh N Acharya (5 out of 7 patents)

bronzeMedal Avraham Hershko (2 out of 2 patents)

4.  Ehud Arbit (1 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oramed Ltd.. Retrieved from https://idiyas.com/company/oramed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…